Palisade Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | +0.0% | +0.0% | -100.0% | – | +0.0% | +0.0% | -100.0% | – | – | – | |
| – | -8.4% | -36.2% | +206.8% | -73.8% | -18.9% | -10.4% | +0.0% | +30.4% | +4,041.1% | +15.3% | +11.4% | – | |
| – | -95.5% | +790.9% | -42.9% | +205.4% | +116.7% | -127.4% | – | -233.8% | – | -33.3% | -228.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +39.3% | -48.7% | -100.0% | – | +40.0% | -49.3% | -100.0% | – | |
| – | -108.5% | – | +76.7% | -105.0% | – | -106.2% | – | +83,975.0% | +3,805.2% | -97.6% | -95.3% | – | |
| – | – | – | – | -4,402.6% | – | -245.5% | – | – | – | -100.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.